Showing results (941-950 of 1,169) with videos related to

Sort By:
Pageof 117
Heart Rhythm|February 6, 2017
The burden of proof: The current state of atrial fibrillation prevention and treatment trialsRosita Zakeri, David R Van Wagoner, Hugh Calkins, et al.
Journal of the American College of Cardiology|December 17, 2016
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II RegistryBenjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
American Heart Journal|September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Intermediate filament dysregulation and astrocytopathy in the human disease model of KLHL16 mutation in giant axonal neuropathy (GAN)Rachel Battaglia, Maryam Faridounnia, Adriana Beltran, et al.
Molecular Biology of the Cell|September 6, 2023
Intermediate filament dysregulation in astrocytes in the human disease model of KLHL16 mutation in giant axonal neuropathy (GAN)Rachel Battaglia, Maryam Faridounnia, Adriana Beltran, et al.
Journal of the American College of Cardiology|February 7, 2006
Predictors of adverse outcome among patients with hypertension and coronary artery diseaseCarl J Pepine, Peter R Kowey, Stuart Kupfer, et al.
Journal of the American College of Cardiology|September 9, 2017
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF RegistryJustin B Echouffo-Tcheugui, Peter Shrader, Laine Thomas, et al.
Pageof 117